These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28163772)

  • 1.
    Bakondi B
    Expert Rev Ophthalmol; 2016; 11(6):397-400. PubMed ID: 28163772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracking CRISPR's Footprints.
    Lin L; Luo Y
    Methods Mol Biol; 2019; 1961():13-28. PubMed ID: 30912037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo CRISPR/Cas9-Mediated Genome Editing Mitigates Photoreceptor Degeneration in a Mouse Model of X-Linked Retinitis Pigmentosa.
    Hu S; Du J; Chen N; Jia R; Zhang J; Liu X; Yang L
    Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):31. PubMed ID: 32330228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR in the Retina: Evaluation of Future Potential.
    Cho GY; Justus S; Sengillo JD; Tsang SH
    Adv Exp Med Biol; 2017; 1016():147-155. PubMed ID: 29130158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAV-Mediated CRISPR/Cas Gene Editing of Retinal Cells In Vivo.
    Hung SS; Chrysostomou V; Li F; Lim JK; Wang JH; Powell JE; Tu L; Daniszewski M; Lo C; Wong RC; Crowston JG; Pébay A; King AE; Bui BV; Liu GS; Hewitt AW
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3470-6. PubMed ID: 27367513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR: express delivery to any DNA address.
    Peterson A
    Oral Dis; 2017 Jan; 23(1):5-11. PubMed ID: 27040868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR GENOME SURGERY IN THE RETINA IN LIGHT OF OFF-TARGETING.
    Cho GY; Schaefer KA; Bassuk AG; Tsang SH; Mahajan VB
    Retina; 2018 Aug; 38(8):1443-1455. PubMed ID: 29746416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Scientists Perceive CRISPR's Translational Promise and the Implications for Individuals with Genetic Conditions.
    Halpern J; O'Hara SE; Owen AL; Paolo D
    Ethics Hum Res; 2021 Nov; 43(6):28-41. PubMed ID: 34751516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized therapeutic strategies for patients with retinitis pigmentosa.
    Zheng A; Li Y; Tsang SH
    Expert Opin Biol Ther; 2015 Mar; 15(3):391-402. PubMed ID: 25613576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Editing Preserves Visual Functions in a Mouse Model of Retinal Degeneration.
    Vagni P; Perlini LE; Chenais NAL; Marchetti T; Parrini M; Contestabile A; Cancedda L; Ghezzi D
    Front Neurosci; 2019; 13():945. PubMed ID: 31551698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of CRISPR/Cas9 in retinal degenerative diseases.
    Peng YQ; Tang LS; Yoshida S; Zhou YD
    Int J Ophthalmol; 2017; 10(4):646-651. PubMed ID: 28503441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of CRISPR/Cas9 technologies combined with iPSCs in the study and treatment of retinal degenerative diseases.
    Cai B; Sun S; Li Z; Zhang X; Ke Y; Yang J; Li X
    Hum Genet; 2018 Sep; 137(9):679-688. PubMed ID: 30203114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome Surgery and Gene Therapy in Retinal Disorders.
    Chan L; Mahajan VB; Tsang SH
    Yale J Biol Med; 2017 Dec; 90(4):523-532. PubMed ID: 29259518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Therapy for Inherited Retinal Degeneration.
    Arbabi A; Liu A; Ameri H
    J Ocul Pharmacol Ther; 2019 Mar; 35(2):79-97. PubMed ID: 30688548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential.
    Oude Blenke E; Evers MJ; Mastrobattista E; van der Oost J
    J Control Release; 2016 Dec; 244(Pt B):139-148. PubMed ID: 27498021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered CRISPR Systems for Next Generation Gene Therapies.
    Pineda M; Moghadam F; Ebrahimkhani MR; Kiani S
    ACS Synth Biol; 2017 Sep; 6(9):1614-1626. PubMed ID: 28558198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
    Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW
    Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome Editing for Inherited Retinal Degenerations.
    Pierce E
    Ophthalmology; 2018 Sep; 125(9):1431-1432. PubMed ID: 30143094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.